Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
Abstract Objectives The objective of this study is to investigate the association between the use of beta‐adrenergic antagonist atenolol and risk of pathologic upgrade in patients on active surveillance, considering growing literature implicating adrenergic innervation with disease progression media...
Saved in:
Main Authors: | Ali H. Zahalka, Ethan Fram, Evan Garden, Lauren Howard, Emily Wiggins, Mustufa Babar, Jay Annam, Allison Reagan, Benjamin Eilender, Amanda deHoedt, Stephen J. Freedland, Ash Tewari, Kara L. Watts |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-11-01
|
Series: | BJUI Compass |
Subjects: | |
Online Access: | https://doi.org/10.1002/bco2.441 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta-adrenergic blocking agents in cutaneous and oral melanoma
by: Sivakamavalli Jeyachandran
Published: (2024-06-01) -
Efficacy of bolus injections of landiolol hydrochloride as premedication in coronary artery CT angiography
by: Mark Barwig, et al.
Published: (2025-01-01) -
Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies
by: Androulla N. Miliotou, et al.
Published: (2025-01-01) -
Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder
by: Jee Soo Park, et al.
Published: (2025-01-01) -
Effect of Nebulisation with Dexmedetomidine versus Magnesium Sulphate on Haemodynamic Response to Laryngoscopy and Intubation and Incidence of Postoperative Sore Throat: A Randomised Clinical Trial
by: Fateh Pal Singh Gill, et al.
Published: (2025-01-01)